Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, People's Republic of China.
ACS Appl Mater Interfaces. 2021 Apr 21;13(15):18033-18046. doi: 10.1021/acsami.1c02567. Epub 2021 Apr 9.
Natural killer (NK) cell-based immunotherapy presents a promising antitumor strategy and holds potential for combination with chemotherapy. However, the suppressed NK cell activity and poor tumor retention of therapeutics hinder the efficacy. To activate NK cell-based immuno-chemotherapy and enhance the tumor retention, we proposed a pH-responsive self-aggregated nanoparticle for the codelivery of chemotherapeutic doxorubicin (DOX) and the transforming growth factor-β (TGF-β)/Smad3 signaling pathway inhibitor SIS3. Polycaprolactone-poly(ethylene glycol) (PCL-PEG) micelles modified with dibenzylcyclooctyne (DBCO) or azido (N) and coated with acid-cleavable PEG were established. This nanoplatform, namely, M-DN@DOX/SIS3, could remain well dispersed in the neutral systemic circulation, while quickly respond to the acidic tumor microenvironment and intracellular lysosomes, triggering copper-free click reaction-mediated aggregation, leading to the increased tumor accumulation and reduced cellular efflux. In addition, the combination of DOX with SIS3 facilitated by the aggregation strategy resulted in potent inhibition of melanoma tumor growth and significantly increased NK cells, NK cell cytokines, and antitumor T cells in the tumor. Taken together, our study offered a new concept of applying copper-free click chemistry to achieve nanoparticle aggregation and enhance tumor retention, as well as a promising new combined tumor treatment approach of chemotherapy and immunotherapy.
自然杀伤 (NK) 细胞为基础的免疫疗法提供了一种有前途的抗肿瘤策略,并有可能与化疗结合。然而,治疗剂的 NK 细胞活性受抑和肿瘤滞留不良限制了其疗效。为了激活 NK 细胞免疫化疗并增强肿瘤滞留,我们提出了一种 pH 响应自聚集纳米粒子,用于共递送化疗药物多柔比星 (DOX) 和转化生长因子-β (TGF-β)/Smad3 信号通路抑制剂 SIS3。用二苄基环辛炔 (DBCO) 或叠氮 (N) 修饰的聚己内酯-聚乙二醇 (PCL-PEG) 胶束,并涂有可酸裂解的 PEG。这种纳米平台,即 M-DN@DOX/SIS3,在中性的全身循环中可以很好地分散,而在酸性的肿瘤微环境和细胞内溶酶体中迅速响应,触发无铜点击反应介导的聚集,导致肿瘤积累增加和细胞外排减少。此外,通过聚集策略促进的 DOX 与 SIS3 的组合导致黑色素瘤肿瘤生长的强烈抑制,并显著增加了肿瘤中的 NK 细胞、NK 细胞细胞因子和抗肿瘤 T 细胞。总之,我们的研究为应用无铜点击化学实现纳米颗粒聚集和增强肿瘤滞留提供了一个新概念,并为化疗和免疫治疗相结合的肿瘤治疗提供了一种很有前途的新方法。